Abstract:BACKGROUND: Cancer is one of the leading causes of death worldwide. Over the years, a number of conventional cytotoxic approaches for neoplastic diseases has been developed. However, due to their limited effectiveness in accordance with the heterogeneity of cancer cells, there is a constant search for therapeutic approaches with improved outcome, such as immunotherapy that utilizes and enhances the normal capacity of the patient's immune system.METHODS: Chimeric Antigen Receptor (CAR) T-cell therapy involves genetic modification of patient's autologous T-cells to express a CAR specific for a tumor antigen, following by ex vivo cell expansion and re-infusion back to the patient. CARs are fusion proteins of a selected single-chain fragment variable from a specific monoclonal antibody and one or more T-cell receptor intracellular signaling domains. This T-cell genetic modification may occur either via viral-based gene transfer methods or nonviral methods, such as DNA-based transposons, CRISPR/Cas9 technology or direct transfer of in vitro transcribed-mRNA by electroporation.RESULTS: Clinical trials have shown very promising results in end-stage patients with a full recovery of up to 92% in Acute Lymphocytic Leukemia. Despite such results in hematological cancers, the effective translation of CAR T-cell therapy to solid tumors and the corresponding clinical experience is limited due to therapeutic barriers, like CAR T-cell expansion, persistence, trafficking, and fate within tumors.CONCLUSION: In this review, the basic design of CARs, the main genetic modification strategies, the safety matters as well as the initial clinical experience with CAR T-cells are described.

CAR-T Cell Therapy: Revolutionizing Cancer Treatment

Revolutionizing cancer treatment: a comprehensive review of CAR-T cell therapy

Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies

CAR‐T Therapy in Clinical Practice: Technical Advances and Current Challenges

Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures

CAR-T cell therapy: a game-changer in cancer treatment and beyond

Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies

Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy

CAR‐T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

CAR-T in cancer therapeutics and updates

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments

Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies

Current progress in CAR-T cell therapy for tumor treatment

Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Methodology, Applications and Advancements of Car-T Cell Therapy in Malignancies

Current Progress in CAR-T Cell Therapy for Solid Tumors

CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges

CAR-T cell therapy: current limitations and potential strategies